Attached files
file | filename |
---|---|
10-K - FORM 10-K - Actavis, Inc. | a55319e10vk.htm |
EX-31.2 - EX-31.2 - Actavis, Inc. | a55319exv31w2.htm |
EX-21.1 - EX-21.1 - Actavis, Inc. | a55319exv21w1.htm |
EX-31.1 - EX-31.1 - Actavis, Inc. | a55319exv31w1.htm |
EX-32.1 - EX-32.1 - Actavis, Inc. | a55319exv32w1.htm |
EX-32.2 - EX-32.2 - Actavis, Inc. | a55319exv32w2.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3
(Nos. 333-70943, 333-53312, 333-105816, 333-161404) and Form S-8 (Nos. 333-05737, 333-24577,
333-37733, 333-70933, 333-38596, 333-45650, 333-53334, 333-61844, 333-61842, 333-102285,
333-111032, 33-144039) of Watson Pharmaceuticals, Inc. of our report dated March 1, 2010 relating
to the financial statements, financial statement schedule and the effectiveness of internal control
over financial reporting, which appears in this Form 10-K.
PricewaterhouseCoopers LLP
Orange County, CA
March 1, 2010
Orange County, CA
March 1, 2010